Investigating diversity in human plasma proteins

被引:145
作者
Nedelkov, D [1 ]
Kiernan, UA [1 ]
Niederkofler, EE [1 ]
Tubbs, KA [1 ]
Nelson, RW [1 ]
机构
[1] Intrinsic Bioprobes Inc, Tempe, AZ 85281 USA
关键词
mass spectrometry; population proteomics; protein modifications;
D O I
10.1073/pnas.0500426102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Plasma proteins represent an important part of the human proteome. Although recent proteomics research efforts focus largely on determining the overall number of proteins circulating in plasma, it is equally important to delineate protein variations among individuals, because they can signal the onset of diseases and be used as biological markers in diagnostics. To date, there has been no systematic proteomics effort to characterize the breadth of structural modifications in individual proteins in the general population. In this work, we have undertaken a population proteomics study to define gene- and protein-level diversity that is encountered in the general population. Twenty-five plasma proteins from a cohort of 96 healthy individuals were investigated through affinity-based mass spectrometric assays. A total of 76 structural forms/variants were observed for the 25 proteins within the samples cohort. Posttranslational modifications were detected in 18 proteins, and point mutations were observed in 4 proteins. The frequency of occurrence of these variations was wide-ranged, with some modifications being observed in only one sample, and others detected in all 96 samples. Even though a relatively small cohort of individuals was investigated, the results from this study illustrate the extent of protein diversity in the human population and can be of immediate aid in clinical proteomics/biomarker studies by laying a basal-level statistical foundation from which protein diversity relating to disease can be evaluated.
引用
收藏
页码:10852 / 10857
页数:6
相关论文
共 29 条
[1]   The human plasma proteome - A nonredundant list developed by combination of four separate sources [J].
Anderson, NL ;
Polanski, M ;
Pieper, R ;
Gatlin, T ;
Tirumalai, RS ;
Conrads, TP ;
Veenstra, TD ;
Adkins, JN ;
Pounds, JG ;
Fagan, R ;
Lobley, A .
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) :311-326
[2]   Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency) [J].
Carchon, H ;
Van Schaftingen, E ;
Matthijs, G ;
Jaeken, J .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1999, 1455 (2-3) :155-165
[3]   Finishing the euchromatic sequence of the human genome [J].
Collins, FS ;
Lander, ES ;
Rogers, J ;
Waterston, RH .
NATURE, 2004, 431 (7011) :931-945
[4]   Tabulation of human transthyretin (TTR) variants, 2003 [J].
Connors, LH ;
Lim, A ;
Prokaeva, T ;
Roskens, VA ;
Costello, CE .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2003, 10 (03) :160-184
[5]  
Craig W.Y., 2000, PLASMA PROTEINS CLIN
[6]   Mass Spectrometry as a diagnostic and a cancer biomarker discovery tool - Opportunities and potential limitations [J].
Diamandis, EP .
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) :367-378
[7]   A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-dericient transferrin levels [J].
Fleming, MF ;
Anton, RF ;
Spies, CD .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (09) :1347-1355
[8]  
JACOBSON DR, 1995, HUM GENET, V95, P308
[9]   Clinical proteomics and biomarker discovery [J].
Johann, DJ ;
McGuigan, MD ;
Patel, AR ;
Tomov, S ;
Ross, S ;
Conrads, TP ;
Veenstra, TD ;
Fishman, DA ;
Whiteley, GR ;
Petricoin, EF ;
Liotta, LA .
CIRCULATING NUCLEIC ACIDS IN PLASMA/SERUM III AND SERUM PROTEOMICS, 2004, 1022 :295-305
[10]   Proteomic characterization of novel serum amyloid P component variants from human plasma and urine [J].
Kiernan, UA ;
Nedelkov, D ;
Tubbs, KA ;
Niederkofler, EE ;
Nelson, RW .
PROTEOMICS, 2004, 4 (06) :1825-1829